Finance

Lists
JNJB34:BVMF
Johnson & Johnson BDR
R$84.30
0.00%
(0.00) 1D
Oct 5, 5:06:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for JNJB34...
Open
R$88.70
High
R$88.70
Low
R$84.00
Mkt. cap
609.54B
Avg. vol.
8.33K
Volume
25.80K
52-wk high
R$96.19
52-wk low
R$64.02
Shares outstanding
2.41B
No. of employees
138K
Open
R$88.70
High
R$88.70
Low
R$84.00
Mkt. cap
609.54B
Avg. vol.
8.33K
Volume
25.80K
52-wk high
R$96.19
52-wk low
R$64.02
Shares outstanding
2.41B
No. of employees
138K
News stories
From web sources and news partners
About Johnson & Johnson BDR
CEOJoaquin Duato
Employees138K
FoundedJan 1886
HeadquartersNew Brunswick, New Jersey, United States
SectorPharmaceutical industry
Websitejnj.com
Next call in 7 days
Tue, Oct 13, 2:30 PM
Fiscal period
Q3 2026
EPS / Est. (USD)
- / $2.48
Revenue / Est. (USD)
- / 25.32B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
23.99B
24.56B
24.06B
25.31B
Cost of goods sold
7.29B
7.81B
8.09B
8.02B
Cost of revenue
7.29B
7.81B
8.09B
8.02B
Research and development expenses
3.67B
4.25B
3.53B
3.65B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.78B
6.61B
5.85B
6.25B
Operating expense
9.46B
10.86B
9.38B
9.91B
Total operating expenses
16.75B
18.68B
17.47B
17.92B
Operating income
7.25B
5.89B
6.60B
7.39B
Other non operating income
17.00M
396.00M
-211.00M
110.00M
EBT including unusual items
7.49B
4.97B
5.99B
6.75B
EBT excluding unusual items
7.27B
6.03B
6.41B
7.42B
Income tax expense
2.34B
-150.00M
755.00M
1.21B
Effective tax rate
31.24%
-3.02%
12.60%
17.98%
Other operating expenses
-
-
-
-
Net income
5.15B
5.12B
5.24B
5.53B
Net profit margin
21.47%
20.83%
21.76%
21.86%
Earnings per share
2.80
2.46
2.70
2.90
Interest and investment income
227.00M
237.00M
229.00M
219.00M
Interest expense
-245.00M
-214.00M
-272.00M
-281.00M
Net interest expenses
-18.00M
23.00M
-43.00M
-62.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
9.02B
7.90B
8.60B
9.35B
Gain or loss from assets sale
-57.00M
-132.00M
12.00M
-55.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps